國際實業(000159.SZ):取消將萬家基金40%股權劃轉至北京中昊泰睿投資名下
格隆匯 12 月 29日丨國際實業(000159.SZ)公佈,公司第七屆董事會第十九次會議決議,審議通過《關於取消內部劃轉萬家基金管理有限公司股權的議案》;
公司曾於2019年10月30日召開第七屆董事會第十四次會議審議通過《關於對部分子公司股權進行內部劃轉的議案》,其中將持有的萬家基金管理有限公司(“萬家基金”)40%股權內部劃轉至北京中昊泰睿投資有限公司(以下簡稱“北京中昊泰睿”)名下,一直未實施。現因擬將北京中昊泰睿100%股權對外轉讓,公司決定取消將萬家基金40%股權劃轉至北京中昊泰睿投資有限公司名下,公司仍繼續持有萬家基金40%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.